文献速递心脏核医学神经核医学骨显像与常规 SPECT

遗传性转甲状腺素蛋白淀粉样变性心脏神经支配显像:心衰时反映心肌病还是神经病变?

Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
PubMed 文献 · J Nucl Cardiol · 2018-10-29

研究纳入39例TTR突变携带者及ATTRm患者,评估123I-MIBG与99mTc-HDP显像同心肌病及心脏自主神经病变标志物的相关性。结果显示,合并心肌病者(无论有无自主神经病变)晚期HMR均低于无心肌病者,且HMR与 wash-out 分别与NT-proBNP及99mTc-HDP摄取相关,提示心衰时123I-MIBG显像反映心肌病而非心脏自主神经病变,并可能早于骨显像异常。

要点

  • 心衰时123I-MIBG显像反映心肌病而非心脏自主神经病变。
  • 合并心肌病者晚期HMR低于无心肌病者(P<0.001)。
  • HMR与wash-out分别与NT-proBNP及99mTc-HDP摄取相关。

核心结论

  • 在心衰情况下,ATTRm患者及TTR突变携带者的123I-MIBG显像反映心肌病而非心脏自主神经病变。
  • 123I-MIBG显像可能在心脏骨显像剂摄取可见之前即已异常。

研究设计与样本

  • 纳入所有接受123I-MIBG和99mTc-HDP显像的TTR突变携带者及ATTRm患者,共39例(13例携带者,26例ATTRm患者)。
  • 心肌病定义为NT-proBNP > 365 ng/L,心脏自主神经病变定义为自主神经功能试验中心血管反射异常。
  • 异常标准:晚期123I-MIBG HMR < 2.0或wash-out > 20%,以及任何心脏99mTc-HDP摄取。

主要发现

  • 合并心肌病(无论有无心脏自主神经病变)者晚期HMR低于无心肌病者:有心肌病无自主神经病变者中位1.1(范围1.0-1.5) vs 无心肌病无自主神经病变者中位2.4(范围1.4-3.8);有心肌病有自主神经病变者中位1.5(范围1.2-2.6) vs 无心肌病有自主神经病变者中位2.5(范围1.5-3.7),P < 0.001。
  • 晚期HMR与NT-proBNP呈负相关(r = -0.652,P < 0.001),wash-out与NT-proBNP呈正相关(r = 0.756,P < 0.001)。
  • 晚期HMR与心脏99mTc-HDP摄取呈负相关(r = -0.663,P < 0.001),wash-out与心脏99mTc-HDP摄取呈正相关(r = 0.617,P < 0.001)。

关键数值与推荐

  • 心肌病判定阈值:NT-proBNP > 365 ng/L。
  • 123I-MIBG异常标准:晚期HMR < 2.0或wash-out > 20%。
  • 心脏99mTc-HDP摄取:任何摄取视为异常。

临床怎么用

  • 在心衰情况下,123I-MIBG显像结果解读应侧重心肌病评估而非心脏自主神经病变。
  • 123I-MIBG显像可能早于心脏骨显像剂摄取发现异常,可用于早期评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nuclear imaging modalities using 123Iodine-metaiodobenzylguanidine (123I-MIBG) and bone seeking tracers identify early cardiac involvement in ATTRm amyloidosis patients. However, little is known whether results from 123I-MIBG scintigraphy actually correlate to markers for either cardiac autonomic neuropathy or cardiomyopathy. METHODS: All TTR mutation carriers and ATTRm patients who underwent both 123I-MIBG and 99mTechnetium-hydroxymethylene diphosphonate (99mTc-HDP) scintigraphy were included. Cardiomyopathy was defined as NT-proBNP > 365 ng/L, and cardiac autonomic neuropathy as abnormal cardiovascular reflexes at autonomic function tests. Late 123I-MIBG heart-to-mediastinum ratio (HMR) < 2.0 or wash-out > 20%, and any cardiac 99mTc-HDP uptake were considered as abnormal. RESULTS: 39 patients (13 carriers and 26 ATTRm patients) were included in this study. Patients with cardiomyopathy, with or without cardiac autonomic neuropathy, had lower late HMR than similar patients without cardiomyopathy [median 1.1 (range 1.0-1.5) and 1.5(1.2-2.6) vs 2.4 (1.4-3.8) and 2.5 (1.5-3.7), respectively, P < 0.001]. Late HMR and wash-out (inversely) correlated with NT-proBNP r = - 0.652 (P < 0.001) and r = 0.756 (P < 0.001), respectively. Furthermore, late HMR and wash-out (inversely) correlated with cardiac 99mTc-HDP uptake r = - 0.663 (P < 0.001) and r = 0.617 (P < 0.001), respectively. CONCLUSION: In case of heart failure, 123I-MIBG scintigraphy reflects cardiomyopathy rather than cardiac autonomic neuropathy in ATTRm patients and TTR mutation carriers. 123I-MIBG scintigraphy may already be abnormal before any cardiac bone tracer uptake is visible.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Jonker DL, Hazenberg BPC, Nienhuis HLA, et al. Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure? J Nucl Cardiol. 2018. PMID: 30374850. doi:10.1007/s12350-018-01477-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。